Changes in adipose tissue function, morphology, and secretome during obesity impair endothelial cell function and lead to persistent hypoxia and unresolved inflammation, which will
This is a mechanistic review of an emerging drug class with no clinical efficacy data, preclinical results, or trial outcomes reported; it raises scientific questions about molecular glue degraders rather than answering them with evidence.